AbbVie
ABBV
#25
Rank
C$563.97 B
Marketcap
C$319.10
Share price
-0.66%
Change (1 day)
32.04%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$190.44 Billion

According to AbbVie's latest financial reports the company's total liabilities are C$190.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$189.12 B14.7%
2023-12-31C$164.88 B-0.01%
2022-12-31C$164.89 B-1.3%
2021-12-31C$167.07 B-4.68%
2020-12-31C$175.28 B37.95%
2019-12-31C$127.06 B37.58%
2018-12-31C$92.35 B11.83%
2017-12-31C$82.58 B-0.01%
2016-12-31C$82.59 B21.26%
2015-12-31C$68.11 B127.77%
2014-12-31C$29.90 B13.72%
2013-12-31C$26.29 B11.85%
2012-12-31C$23.51 B204.59%
2011-12-31C$7.71 B42.18%
2010-12-31C$5.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$161.33 B-15.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$109.23 B-42.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$127.08 B-33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$112.34 B-41.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$51.73 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.34 B-91.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$85.50 B-55.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
C$95.55 B-49.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.76 B-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA